Optimism turns to concern as Cann Group battles financial uncertainty by Steve Jones March 7, 2024March 7, 2024 With its shares suspended from the ASX amid auditor concern over its ability to keep trading, […]
Financial results: Bioxyne; Rua Bioscience; Bod Science; Avecho; Wellnex Life; MGC Pharma; Cannasouth by Steve Jones March 7, 2024March 7, 2024
Lyphe Australia MD Tracey Loton to go it alone after exiting business by Steve Jones March 6, 2024March 6, 2024
Ecofibre directors ‘unjustly enriched’, former executive alleges as legal action is lodged in the US by Steve Jones March 5, 2024March 5, 2024
Health House parent becomes latest to report financial woes despite revenue growth by Steve Jones March 4, 2024March 6, 2024
Althea to cut further costs amid cash flow concerns and ongoing losses by Steve Jones March 1, 2024March 4, 2024
Cann Group shares suspended as auditor reports ‘insufficient evidence’ of future funding by Steve Jones March 1, 2024March 1, 2024
No imported products tested since new GMP rules came into force, TGA admits, as MCIA calls for meeting by Steve Jones February 29, 2024February 29, 2024
Illicit medical users turning to legal pathways, new data reveals, as support for legalisation grows by Steve Jones February 29, 2024February 29, 2024
